Prothena Competitors and Similar CompaniesClear all

Prothena's competitors and similar companies include Theravance Biopharma, Foundation Medicine, Trans Genic and Quadram Institute.
Prothena
Prothena
Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.
Theravance Biopharma
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.
Foundation Medicine
Foundation Medicine
Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies.
Trans Genic
Trans Genic
Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.
Quadram Institute
Quadram Institute
Quadram Institute is a company specializing in gut health, microbiology, and food.
Founding Date
Founding Date
2012
Founding Date
1996
Founding Date
2010
Founding Date
1998
Founding Date
2017
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Dublin, IE HQ
South San Francisco, US
Locations
Dublin, IE HQ
San Francisco, US
Locations
Boston, US HQ
Penzberg, DE
Morrisville, US
San Diego, US
Locations
Chiyoda City, JP HQ
Locations
Norwich, GB HQ
Employees
Employees
163
Employees
97
Employees
1,8031% decrease
Employees
236
Employees
215
Valuation ($)
Valuation ($)
983.1 m
Valuation ($)
429 m
Valuation ($)
N/A
Valuation ($)
25.6 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
$9.7m (FY, 2025)
Revenue (est.)
$107.5m (FY, 2025)
Revenue (est.)
$152.9m (FY, 2017)
Revenue (est.)
¥13.2b (FY, 2026)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$85.3m (FY, 2017)
Cost of goods
¥10.6b (FY, 2026)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$107.5m (FY, 2025)
Gross profit
$67.6m (FY, 2017)
Gross profit
¥2.6b (FY, 2026)
Gross profit
N/A
Net income
Net income
($244.1m) (FY, 2025)
Net income
$105.9m (FY, 2025)
Net income
($161.5m) (FY, 2017)
Net income
(¥97.5m) (FY, 2026)
Net income
N/A

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
438 (FY, 2018)
Patents (US)
22 (Jul, 2022)
Patents (US)
N/A
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 55m
Total funding raised
$ 96.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Theravance Biopharma
HQ
Dublin, IE
Employees
97

Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.

View company
Foundation Medicine
HQ
Boston, US

Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies.

View company
Trans Genic
HQ
Chiyoda City, JP
Employees
236

Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.

View company
Quadram Institute
HQ
Norwich, GB
Employees
215

Quadram Institute is a company specializing in gut health, microbiology, and food.

View company